Our comprehensive survey of ABC transporter family gene expression identified ABCC1 as an efflux pump that may have particular relevance in mediating T-DXd resistance in breast cancer, offering a strong rationale for its therapeutic targeting. This evidence concerns the gene ABCC1 and breast carcinoma.